AbCellera Biologics Inc. (ABCL)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 48,052 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 20.83% | 12,639 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 119.60% | 33,054 | 0.01 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 23.09% | 5,184 | 0.00 | |
| Q3 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 22,453 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 19,083,744 | 1.93 | |
| Q1 2021 | |||||
| ≡ | Viking Global Investors | Reduce 1.04% | 200,000 | 0.02 | |
| Q4 2020 | |||||
| ≡ | Viking Global Investors | Buy | 19,283,744 | 2.13 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.